Efficacy and safety of thalidomide (1 vs 2 mg/kg per day) in transfusion-dependent thalassemia: a noninferiority trial. // Blood Advances. – URL: https://www.sciencedirect.com/science/article/pii/S2473952926006221?dgcid=rss_sd_all
Efficacy and safety of thalidomide (1 vs 2 mg/kg per day) in transfusion-dependent thalassemia: a noninferiority trial. Blood Advances. https://www.sciencedirect.com/science/article/pii/S2473952926006221?dgcid=rss_sd_all
“Efficacy and safety of thalidomide (1 vs 2 mg/kg per day) in transfusion-dependent thalassemia: a noninferiority trial.” Blood Advances.
@article{article38259,
title = {Efficacy and safety of thalidomide (1 vs 2 mg/kg per day) in transfusion-dependent thalassemia: a noninferiority trial},
journal = {Blood Advances},
url = {https://www.sciencedirect.com/science/article/pii/S2473952926006221?dgcid=rss_sd_all}
}